Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This issue explores the latest choices in HIV regimens for various groups, including youth and older people.
Here are considerations for long-term survivors thinking about switching HIV treatments.
Under 30? Here’s what to consider if you’re thinking about switching HIV treatments.
Switching to a long-acting injectable was right on time for these three people living with HIV.
Lenacapavir, a twice-yearly injectable, suppresses viral load in people with highly resistant virus.
Long-acting injections given every two months could soon offer a new option for HIV pre-exposure prophylaxis.
Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.
People who used long-acting Cabenuva preferred the injections over their previous daily oral regimen.
Twice monthly injections for HIV prevention could be approved early next year.
Switching HIV treatments from a daily pill to a monthly injectable has given Mike Hellman more freedom outdoors.
From daily pills to long-acting injectables, there are many HIV regimens to consider.
Selecting an HIV regimen depends on doing your homework.
The novel HIV capsid inhibitor also shows promise for previously untreated people.
Awareness of the HIV prevention pills don’t match their use.
Injections given every month or every other month were preferred over daily pills.
Shirley Selvage has built a healthy partnership with her providers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.